Coronavirus Drug Discovery
Volume 2: Antiviral Agents from Natural Products and Nanotechnological Applications
- 1st Edition - July 7, 2022
- Latest edition
- Editor: Chukwuebuka Egbuna
- Language: English
Coronavirus Drug Discovery, Volume Two: Antiviral Agents from Natural Products and Nanotechnological Applications presents detailed information on drug discovery against COVID-19.… Read more
World Book Day celebration
Where learning shapes lives
Up to 25% off trusted resources that support research, study, and discovery.
Description
Description
Coronavirus Drug Discovery, Volume Two: Antiviral Agents from Natural Products and Nanotechnological Applications presents detailed information on drug discovery against COVID-19. Sections in this volume present chapters that focus on the various antiviral agents from natural products that have the propensity to be used as chemical scaffolds for the development of drugs against COVID-19. Also captured are the dietary sources of antioxidant bioactives that may help boost the immune system for the management of COVID-19. Other chapters describe the application of nanotechnology for efficient and effective delivery of drugs against COVID-19.
Written by global team of experts, this book is an excellent resource for drug developers, medicinal chemists, pharmaceutical companies in R&D and research institutes in both academia and industry.
Key features
Key features
- Presents the various antiviral bioactive compounds from natural products
- Discusses the roles of antioxidant in the prevention and management of COVID-19
- Details the application of nanotechnology for efficient and effective drug delivery
Readership
Readership
Researchers in organic and medicinal chemistry including drug developers and medicinal chemists, virologists, toxicologists, analytical chemists.Researchers in pharmaceutical and biotech industries
Table of contents
Table of contents
PART I: ANTIVIRAL AGENTS FROM NATURAL PRODUCTS
1. COVID-19 management and phytomedicine interventions: Potentials and safety considerations
2. Plants with potent antiviral properties
3. Antiviral effects of medicinal plants and their active phytochemical constituents against respiratory diseases and associated biological functions
4. Herbs and drugs in clinical trials for coronavirus treatments
5. Herbal-Based Resources against Exanthematous Viral Infections and Other Viral Diseases
6. Dietary polyphenols as therapeutic agents to combat COVID-19
7. Bioactive compounds and herbal preparations implicated in for the treatment of SARS-CoV-2
8. Roles of Antioxidants in the Prevention and Management of Coronavirus Disease 2019
9. Food sources of natural antioxidants for body defence against SARS-CoV-2
10. Nutritional Management against Severe Acute Respiratory Syndrome Coronavirus-2 Infection
Product details
Product details
- Edition: 1
- Latest edition
- Published: July 7, 2022
- Language: English
About the editor
About the editor
CE
Chukwuebuka Egbuna
Chukwuebuka Egbuna (PhD) is a chartered chemist and academic researcher. He is a member of the Institute of Chartered Chemists of Nigeria (ICCON), the Nigerian Society of Biochemistry and Molecular Biology (NSBMB), and the Royal Society of Chemistry (RSC) (United Kingdom). Dr. Egbuna is the founder and editor of the Elsevier book series on Drug Discovery Update. The series includes books, monographs, and edited collections from all areas of drug discovery including emerging therapeutic claims for the treatment of diseases. He has published research articles in many international journals of repute and is ranked among the top 500 Nigerian scientists in SciVal/SCOPUS. He has edited more than 25 books with Elsevier, Springer, Wiley, and Taylor & Francis. His most recent book is the three volume Coronavirus Drug Discovery, published by Elsevier. Dr. Egbuna is the founder and the publishing director of IPS Intelligentsia Publishing Services.